부평 다이어트 병원 추천해 줘
Weight-Loss ClinicsNamed in 2 of 21 answers
#11
11.4
Brand profile
위고비
덴마크 제약사 노보 노디스크가 개발한 비만 치료 주사제로, GLP-1 유사체 세마글루티드를 주성분으로 하며 2021년 미국 FDA 승인을 받았습니다.
1 questions, 1 categoriesAs of Nov 12, 2026
- Questions
- 1
- 1 categories
- Answers naming it
- 2/21
- Of the answers measured on this brand's questions
Visibility by category
| Categories | Category rank | Questions | Score |
|---|---|---|---|
| Weight-Loss Clinics | - | 1 | 11.4 |
Ranking by question
Sources cited when this brand is named
Sites the answers naming this brand cited in the last four weeks. Counts are citing answers.
The answers that named this brand cited no sources in the last four weeks.
Named by surface, by question
For the brand's best questions: of each surface's 3 answers, how many named it.
| Questions |  Google AI Overviews |  ChatGPT |  Claude |  Gemini | Google AI Mode |  Microsoft Copilot |
|---|---|---|---|---|---|---|
| 1부평 다이어트 병원 추천해 줘 | 0 | 0 | 0 | - | 0 | 0 |
Where it is ranked
Best rank of the brand or its branches in each region.
Korea